LAMOTRIGINE
- Product NDC
- 43063-259
- 11-digit product format
- 430630259
- Labeler code
- 43063
- Product ID
- 43063-259_db70db85-2e89-893c-e053-2a95a90a4be2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- LAMOTRIGINE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA078947
- Marketing category
- ANDA
- Marketing start
- 2009-01-27
- Marketing end
- 0000-00-00
- Substance
- LAMOTRIGINE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-259-30 | 43063025930 | 30 TABLET in 1 BOTTLE, PLASTIC (43063-259-30) | 30 tablet | 2009-08-06 | 0000-00-00 | No | No | Current |
| 43063-259-60 | 43063025960 | 60 TABLET in 1 BOTTLE, PLASTIC (43063-259-60) | 60 tablet | 2009-08-06 | 0000-00-00 | No | No | Current |